2007 June 28 AOI Medical raised £8 million in a listing on the Alternative Investment Market (AIM) in London. The company issued 2.3 million shares at £P3.44 each, giving a market capitalisation of £29 million.
Since incorporation in November 2004, the Company has progressed the development of three separate key technology platforms:
Ascendx VCF Reduction System (“Ascendx”)
a set of tools for use in restoring the anatomical integrity of vertebra. This is
intended to address a vertebral compression fracture (“VCF”) of the spine
caused by osteoporosis or trauma.
Balloon Assisted Management of Trauma Fractures (“BAMF Trauma”)
a removable, expandable rod for the stabilization of fractures of the long bones
of the arms and legs.
Motion Preserving Cervical Dynamic Stabilization Plate (“Cervical Plate”)
an anterior, semi-constrained artificial ligament providing limited translational and
rotational stabilization forces at the site of an intervertebral graft, implant or
prosthesis subsequent to cervical spine surgery.
www.aoimedical.net
